Patent 10952894 was granted and assigned to Clearside BioMedical, Inc. on March, 2021 by the United States Patent and Trademark Office.
The present invention provides devices to access the suprachoroidal space or sub-retinal space in an eye via a minimally invasive transconjunctival approach. The devices may also be used after a partial dissection, for example after dissection of the outer scleral layer of the eye, and using the device within the dissection to access the suprachoroidal space or the sub-retinal space.